about
Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potentialPET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular LymphomasRadiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment optionA synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLAFBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?Tumor suppressors in follicular lymphoma.Rituximab by subcutaneous route.Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas.Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study.Diagnostic Pitfalls in "Low-Grade Lymphoma" of the Orbit and Lacrimal Gland.Obinutuzumab for the treatment of indolent lymphomaObinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma.Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy.Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motifWater-only fasting and an exclusively plant foods diet in the management of stage IIIa, low-grade follicular lymphoma.Parameters for Contrast-Enhanced Ultrasound (CEUS) of Enlarged Superficial Lymph Nodes for the Evaluation of Therapeutic Response in Lymphoma: A Preliminary Study.Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma.Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.Unmet needs in the first-line treatment of follicular lymphoma.[Current treatment strategies for follicular lymphoma].Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma.
P2860
Q26747753-5F84E921-B344-40B6-A92E-B5A999F2E182Q26752284-12343971-7D53-4101-8E41-C86DB93322C0Q28079951-9318D7E0-A8EB-44AC-BE3C-6D50F0B5C357Q36413780-8657D6C5-CF3F-4D12-B0D7-4A080A6675D4Q37012701-44D76BD1-76B3-4AB3-BE87-765A17293F8EQ37404843-42A5F07A-5926-4C12-9E00-F4636B0017B4Q37577874-B10C0C8C-F1F6-4922-91AD-E217AD432318Q38266066-29E5CD12-A764-4622-83F2-1DA7D48B629BQ38369983-4525313B-FFFC-48E0-AEA8-42F4CBC50502Q38416175-626C6E32-4792-450F-AF99-1D1509707858Q38419117-470FB718-6117-47ED-8A45-ECE286364BD5Q38515805-F0D844B5-15B7-4770-863A-07DE5160BC13Q38818380-634950F7-CAA2-49FA-826B-0B28933F74D2Q38889978-531A6FCE-888A-4277-9C32-84EFE46F5D6CQ39353147-8C307FB9-14B3-4BA6-A2BD-C81FD5654CC3Q39599883-FE77DABB-C54C-4C19-9D7E-2895984588C8Q40449915-580E15BF-FC76-4446-9CA9-5439B9AD3114Q42630555-687C556B-2D5F-4D87-9B76-0E005B28CCA5Q46017945-D58ECEA5-C00B-4232-8CFA-C53D6E376AACQ47130685-F1B0229E-88A5-43AA-BF86-9F8339184905Q47143348-EDBE0A6A-CA23-4402-80C6-A37A25C9DB8FQ47731613-AF20C768-4D4E-415B-B8DF-9014E2C810D6Q47830676-76AB7BD0-1337-4997-A101-D3316FB4EEFCQ50710717-6843C3D2-D945-4BC3-A35D-59BC9A3BD8C3Q53185261-D921242A-3DA5-4E40-B3FC-42E310BD9748Q53602202-1CA4A673-B712-4EC3-A841-FB0A05E1D4D6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
How we manage follicular lymphoma.
@en
type
label
How we manage follicular lymphoma.
@en
prefLabel
How we manage follicular lymphoma.
@en
P2860
P356
P1433
P1476
How we manage follicular lymphoma.
@en
P2093
B D Cheson
W Hiddemann
P2860
P2888
P304
P356
10.1038/LEU.2014.91
P577
2014-02-28T00:00:00Z
P5875
P6179
1025813325